French automotive technology supplier Forvia has secured a multi-year contract to supply “several hundred thousand” complete seat sets to Luxeed.
According to the press statement, the agreement is valued at “several hundred million euros”, although the exact figure was not disclosed.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It covers supply of complete seat systems for Luxeed models.
Luxeed is a high-end EV marque launched in 2023 under Chinese carmaker Chery. It already sells two passenger models, the Luxeed R7 and S7, and is also working on a people-mover that is still being developed.
Seat assembly will be carried out at a dedicated site in Wuhu, southeast China, where the company plans to install a new production line for the programme.
Forvia Seating executive vice president Sébastien Limousin said: “This is a major first agreement with one of China’s most dynamic automotive manufacturers and it significantly expands our strategic position in China.
“Luxeed’s trust in Forvia’s innovations demonstrates the value of our focus on automated, individualised, and context-aware seating experiences.”
Components, mechanisms and seat structures will be sourced from Forvia plants in Jiaxing, Wuxi and Yancheng.
The contract also includes adoption of technologies from Forvia’s Transformer Seat concept, presented at Auto Shanghai last year.
These seats will feature automatic, real-time adjustment according to occupant morphology and driving conditions, supported by dedicated algorithms.
The seat systems will incorporate lightweight metal frames and zero-gravity reclining functions intended to distribute body weight more evenly and ease spinal and joint strain.
The programme follows an accelerated industrialisation schedule.
All production preparations, including construction of the Wuhu line, are planned within roughly six months with support from Forvia’s China headquarters teams.
Production is scheduled to begin in August this year.
Last December, Forvia, Michelin and Stellantis agreed to a restructuring and refinancing package for their hydrogen fuel cell joint venture Symbio after months of uncertainty over its future.
The three partners each hold a 33% stake and have endorsed a plan to significantly scale down operations and refocus activities.
